PLAY PODCASTS
Virtual COVID-19 2020 Conference: Rapid Audio Recap
Episode 9

Virtual COVID-19 2020 Conference: Rapid Audio Recap

Hear insights from Renslow Sherer, MD, on some of the most important new data reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, with a focus on studies of investigational COVID-19 treatment strategies.

Decera Clinical Education Infectious Disease Podcast · Renslow Sherer MD

August 19, 202043m 30s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment of severe COVID-19.

Presenter:

Renslow Sherer, MD
Director, International HIV Training Center
Professor of Medicine
University of Chicago
Chicago, Illinois

Content based on a CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://bit.ly/2Q7GDp2


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

remdesivirremdesivir covid-19race remdesivirhydroxychloroquine covid-19race remdesivir covid-19ethnicity remdesivirhydroxychloroquine remdesivirhydroxychloroquinecovid-19 mortalityethnicity remdesivir covid-19sofosbuvir daclatasvir lopinavir/ritonavir covid-19hydroxychloroquine remdesivir covid-19lopinavir/ritonavir covid-19covid-19 conferencesofosbuvir daclatasvir covid-19